Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

Table 3 Study group (intervention or control group) in relation to the concordance between influential side effects and 6-month treatment choice

6-month treatment choice	Cases^a/ Total^b	Unadjusted		Adjusted^c
		OR	95%CI	OR	95%CI
All treatments	211 / 448	0.82	(0.56, 1.2)	0.76	(0.51, 1.2)
Active surveillance	39 / 68	0.38	(0.14, 1.0)	0.16	(0.03, 0.79)
External beam radiotherapy	28 / 94	1.2	(0.51, 3.0)	1.3	(0.49, 3.7)
Brachytherapy	23 / 63	0.98	(0.32, 3.0)	0.96	(0.11, 8.3)
Prostatectomy	121 / 223	0.90	(0.53, 1.5)	0.87	(0.49, 1.6)

a. Number of concordant cases.
b. Total number treated.
c. Adjusted for health care site, age at enrollment, full-time work status, health insurance type, internet as an information source for prostate cancer, trait anxiety, age as a factor in treatment choice, influence of recreational or work activities as considering treatment choice, importance or influence of confidence or lack of confidence in a particular doctor in treatment choice, and importance or influence of survival on treatment choice.

ISSN: 1477-7525